Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Redox Reactions01:27

Redox Reactions

1.4K
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
1.4K
Redox Reactions01:24

Redox Reactions

59.5K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
59.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

579
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
579
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Removal notice to Seasonal patterns in diagnosis of chronic coronary syndrome by Ct-angiography -a retrospective single-center experience with 10.022 patients [J Cardiovasc Comp Tomogr 20 (2026) S18].

Journal of cardiovascular computed tomography·2026
Same author

REMOVED: Seasonal Patterns In Diagnosis Of Chronic Coronary Syndrome By Ct-angiography -a Retrospective Single-center Experience With 10.022 Patients.

Journal of cardiovascular computed tomography·2026
Same author

Prognostic impact of disease-related complications in asymptomatic mitral regurgitation: a health insurance claims analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2024
Same author

Exercise related versus non exercise related out of hospital cardiac arrest - A retrospective single-center study.

Resuscitation plus·2024
Same author

[Curriculum "Tracheostomy management in dysphagia therapy"].

HNO·2024
Same author

[Curriculum "Tracheostomy management in dysphagia therapy"].

Der Nervenarzt·2024

Related Experiment Video

Updated: Apr 16, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.6K

Redox-sensitive mechanisms underlying vascular dysfunction in heart failure.

J Konradi1, M Mollenhauer, S Baldus

  • 1Department III of Internal Medicine, Heart Centre, University of Cologne , Cologne , Germany.

Free Radical Research
|March 20, 2015
PubMed
Summary

Heart failure (HF) involves vascular dysfunction driven by oxidative stress. Understanding reactive oxygen species (ROS) sources and their impact on blood vessels is key for developing new HF therapies.

Keywords:
dysfunctionheart failurereactive oxygen speciesvascular

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.2K
Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 16, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.6K
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.2K
Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.3K

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Oxidative Stress Research

Background:

  • Despite advances, heart failure (HF) outcomes remain poor.
  • Impaired cardiac function triggers detrimental vascular changes, including inflammation and hypoxia.
  • Oxidative stress, marked by increased reactive oxygen species (ROS), significantly impacts vascular integrity.

Purpose of the Study:

  • To explore the mechanisms initiating vascular dysfunction in HF pathogenesis.
  • To elucidate the role of oxidative stress in HF-related vascular changes.
  • To review the sources of ROS in the vasculature and their impact.

Main Methods:

  • Literature review summarizing current research on oxidative stress and vascular dysfunction in HF.
  • Analysis of the link between ROS, vascular remodeling, and HF progression.
  • Discussion of potential therapeutic targets.

Main Results:

  • Oxidative stress is a critical factor in vascular dysfunction in HF.
  • ROS contribute to both functional and structural vascular remodeling.
  • Vascular dysfunction plays a significant role in HF development and progression.

Conclusions:

  • Vascular dysfunction is a crucial, yet not fully understood, component of HF.
  • Targeting oxidative stress and vascular mechanisms offers promising therapeutic avenues for HF.
  • Further research is needed to fully elucidate the pathways involved and develop effective treatments.